3 European Growth Companies With Up To 19% Insider Ownership

As European markets navigate a landscape marked by cautious optimism amid U.S. trade policy developments and geopolitical efforts, investors are increasingly focused on companies with strong growth potential. In this environment, stocks with high insider ownership can be particularly appealing, as they often indicate confidence in the company's future prospects from those closest to its operations.

Top 10 Growth Companies With High Insider Ownership In Europe

Name	Insider Ownership	Earnings Growth
TF Bank (OM:TFBANK)	15.6%	20%
CD Projekt (WSE:CDR)	29.7%	39.4%
Bergen Carbon Solutions (OB:BCS)	12%	50.8%
Truecaller (OM:TRUE B)	29.7%	24.8%
XTPL (WSE:XTP)	27.9%	118%
BioArctic (OM:BIOA B)	33.8%	38.5%
Pharma Mar (BME:PHM)	11.9%	45.4%
Smart Eye (OM:SEYE)	13.7%	127.8%
Elliptic Laboratories (OB:ELABS)	22.6%	121.1%
MedinCell (ENXTPA:MEDCL)	13.9%	114.3%

Click here to see the full list of 212 stocks from our Fast Growing European Companies With High Insider Ownership screener.

We'll examine a selection from our screener results.

Lectra (ENXTPA:LSS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lectra SA offers industrial intelligence solutions for the fashion, automotive, furniture markets, and other industries globally, with a market cap of €1.09 billion.

Operations: The company's revenue segments are distributed as follows: €176.10 million from the Americas, €131.53 million from the Asia-Pacific region, and €219.05 million from EMEA (Europe, Middle East, and Africa).

Insider Ownership: 17.7%

Lectra's growth prospects are promising, with earnings expected to increase significantly, outpacing the French market. Revenue is forecasted to grow at 6% annually, slightly above the market average. Despite a low return on equity forecast of 13.2%, Lectra trades at a discount of 24.5% below its estimated fair value. Recent developments include steady financial performance and upcoming board changes due to director resignation, while revenue guidance for 2025 suggests continued growth momentum.

• Get an in-depth perspective on Lectra's performance by reading our analyst estimates report here.
• According our valuation report, there's an indication that Lectra's share price might be on the cheaper side.

MedinCell (ENXTPA:MEDCL)

Simply Wall St Growth Rating: ★★★★★★

Overview: MedinCell S.A. is a pharmaceutical company based in France that focuses on developing long-acting injectables across various therapeutic areas, with a market cap of €472.03 million.

Operations: The company generates revenue of €13.20 million from its pharmaceuticals segment, which involves the development of long-acting injectables in diverse therapeutic fields.

Insider Ownership: 13.9%

MedinCell demonstrates strong growth potential with revenue expected to increase by 65.3% annually, surpassing the French market's growth rate. The company's strategic partnerships, such as with Teva Pharmaceuticals for UZEDY, bolster its development pipeline. Recent capital raises of €50.9 million enhance financial flexibility despite a volatile share price and negative equity concerns. MedinCell is forecasted to become profitable within three years, reflecting robust future prospects amidst high insider ownership stability.

• Delve into the full analysis future growth report here for a deeper understanding of MedinCell.
• The valuation report we've compiled suggests that MedinCell's current price could be quite moderate.

Ratos (OM:RATO B)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Ratos (ticker: OM:RATO B) is a Swedish investment company that focuses on acquiring and developing unlisted medium-sized Nordic companies, with a market cap of SEK12.82 billion.

Operations: The company generates revenue from three main segments: Consumer (SEK5.34 billion), Industry (SEK10.41 billion), and Construction & Services (SEK16.38 billion).

Insider Ownership: 19.4%

Ratos is poised for growth with earnings projected to expand significantly at 38.3% annually, outpacing the Swedish market. Despite a challenging year with a net loss in Q4, revenue is forecasted to grow faster than the local market. Recent leadership changes, including appointing Katarina Ageborg as Chairman and Anna Vilogorac as CFO, aim to strengthen strategic direction. Trading below fair value enhances its appeal amidst high insider ownership and evolving corporate governance dynamics.

• Unlock comprehensive insights into our analysis of Ratos stock in this growth report.
• The analysis detailed in our Ratos valuation report hints at an inflated share price compared to its estimated value.

Next Steps

• Explore the 212 names from our Fast Growing European Companies With High Insider Ownership screener here.
• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com